A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report

Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making. Patients with immune thrombocytopenia have increas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical Case Reports 2021-09, Vol.9 (9), p.n/a
Hauptverfasser:	Takeuchi, Takaya, Matsuura, Yunosuke, Yamamura, Yoshimasa, Ohkusu, Momoko, Koyama, Shohei, Kawaguchi, Takeshi, Akaki Nagayasu, Mayumi, Komatsu, Hiroyuki, Okayama, Akihiko, Ishikawa, Tetsunori, Atsumi, Tatsuya, Kitamura, Kazuo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Anticoagulants anti‐thrombotic therapy Autoimmune diseases Blood clots Blood platelets Blood tests Case Report Case reports Connective tissue Creatinine Disease Drug therapy Edema Glycoproteins Health aspects Hemoglobin immune thrombocytopenia Immunoglobulins Laboratories Lupus Patients Proteins Pulmonary arteries Thrombocytopenia Thromboembolism Thrombosis Ultrasonic imaging Veins & arteries venous thromboembolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making. Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.4805